Open AccessAnticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Author(s) -
Francesco Santoro,
Iván J. NúñezGil,
María C. VianaLlamas,
Charbel Maroun Eid,
Rodolfo Romero,
Inmaculada Fernández Rozas,
Álvaro Alonso,
Víctor Manuel Becerra-Muñoz,
Marcos Garcı́a Aguado,
Jia Huang,
Ludovica Maltese,
Enrico Cerrato,
Emilio Alfonso-Rodríguez,
Alex F. Castro-Mejía,
Francisco Marín,
Sergio RaposeirasRoubín,
Martino Pepe,
Víctor Hugo Moreno Munguía,
Gisela Feltes,
Jesús Varas Navas,
Bernardo Cortese,
L Buzón,
C. Liebetrau,
Raquel Ramos-Martínez,
Antonio Fernández-Ortı́z,
Vicente Estrada,
Natale Daniele Brunetti
Publication year - 2021
Publication title -
critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.002
H-Index - 271
eISSN - 1530-0293
pISSN - 0090-3493
DOI - 10.1097/ccm.0000000000005010
Subject(s) - medicine , prospective cohort study , mortality rate , proportional hazards model , disease , mechanical ventilation , surgery
No standard therapy, including anticoagulation regimens, is currently recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy of anticoagulation in coronavirus disease 2019 hospitalized patients and its impact on survival.